Zantac Wrongful Death Lawsuit Filed Over Fatal Case Of Pancreatic Cancer
A Zantac wrongful death lawsuit claims the recalled heartburn drug caused a man to develop a fatal case of pancreatic cancer due to its high levels of NDMA.…
«
»
A Zantac wrongful death lawsuit claims the recalled heartburn drug caused a man to develop a fatal case of pancreatic cancer due to its high levels of NDMA.…
Interviews for attorneys applying for leadership positions in federal Zantac litigation will be conducted through Zoom videoconferencing.…
A class action lawsuit filed against the makers of Belviq claim they knew about the cancer risks of the recalled weight loss drug before it even hit the market.…
A federal judge has appointed several lawyers to an Initial Census Team and Practices and Procedures Team to help launch Zantac litigation.…
Thousands of Belviq users face an increased cancer risk due to the side effects of the recalled weight loss drug.…
In February 2020, the weight loss drug Belviq was removed from the market, amid concerns that side effects may increase the risk of cancer. Lawsuits and class action claims are now being pursued by former users throughout the United States.…
Belviq cancer concerns arose before the weight loss drug was even approved, but it never carried a cancer warning label.…
The first Zantac MDL conference is scheduled for March 20 to begin pretrial proceedings over claims that NDMA in the recalled heartburn drugs can cause cancer.…
A Zantac lawsuit claims the recalled heartburn drug contains NDMA, a chemical which led to the plaintiff developing pancreatic cancer.…
Side effects of Onglyza, a popular diabetes drug, may increase the risk of serious and potentially life-threatening injuries, including heart failure and pancreatic cancer. …